# Medbio Medbio is an Asset Manager based in Grand Rapids, United States. ## Overview - **Organization type:** Asset Manager - **Headquarters:** Grand Rapids, United States - **Region:** North America - **Address:** Grand Rapids, MI, United States - **Assets under management:** Undisclosed - **Website:** medbiollc.com - **LinkedIn:** https://www.linkedin.com/company/medbio-inc- ## Regulatory record - **Reports private funds:** No ## About Full-Service Medical ManufacturerTaking your medical device from design to completionPlastics News Processor of the Year Finalist & Winner of the 2022 Customer Excellence AwardLearn more Previous slide Next slide ISO 13485:2016 • FDA Registered CleanRoom Molding Our molding presses range in size from 17 ton to 440 ton, including micro-molding and 2-shot machines. We have […] ## Sectors - Medical Devices - Healthcare Services ## Questions ### What does Medbio actually manufacture? Medbio's operating companies injection-mold plastic components, subassemblies, and single-use consumables for medical device OEMs. The firm specializes in cleanroom production of parts that go into orthopedic implants, surgical robotics instruments, and drug-delivery devices. Medbio does not design or own the finished devices — it builds to customer specifications under quality-system certification. ### Who owns Medbio? Medbio has been a portfolio company of Graham Partners, a Philadelphia-based private equity firm, since at least 2019. Graham Partners focuses on advanced manufacturing and industrial technology investments. Medbio operates as a platform that acquires additional injection-molding businesses to integrate into its network. ### Which medical device OEMs does Medbio supply? Medbio has publicly cited relationships with large-cap orthopedic and surgical device manufacturers headquartered in the Midwest. Stryker, the Kalamazoo-based orthopedics and robotics giant, and Zimmer Biomet, the Warsaw, Indiana implant maker, represent the type and geography of OEM customer that sits in Medbio's core supply chain (per industry concentration patterns and Medbio's stated location strategy). ### How does Medbio grow — organically or through acquisition? Medbio uses a hybrid model: it acquires niche medical injection molders with established OEM contracts, then invests in capacity expansion and quality-system maturation to deepen those relationships. This buy-and-build approach under Graham Partners has added facilities across Michigan and New York, including the December 2024 acquisition of Polymer Conversions, which brought metal-to-plastic conversion expertise into the platform. ### What regulatory certifications do Medbio's facilities hold? Medbio's plants operate certified cleanrooms that comply with ISO 13485, the quality-management standard specific to medical device manufacturing, and are FDA-registered establishments. The firm's customer base requires production within these frameworks as a condition of supplier qualification. ### How does Medbio's acquisition strategy affect its supplier relationships? Each acquired facility generally retains its legacy customer contracts and engineering teams. Medbio's value-add is centralized quality-system investment and cross-site capacity coordination. OEMs operating across multiple Medbio sites can access expanded production scale without switching suppliers, which the firm presents as supply-chain continuity rather than vendor consolidation. ## Related profiles - [Fonterra Co-operative Group](https://altss.com/profile/fonterra-co-operative-group-limited) - [Red Collar Pet Foods](https://altss.com/profile/red-collar-pet-foods) --- Last updated: 2026-06-03T20:00:00.000Z Canonical page: https://altss.com/profile/medbio Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology